What We're Reading: Page 105
Industry reads hand-picked by our editors
Aug 24, 2022
-
Axios
Democrats’ drug pricing law puts cancer drugs in the spotlight
-
Bloomberg
Pfizer Bidding War With J&J Preceded Global Blood Therapeutics Deal
-
The New York Times
Biden Administration Plans for Booster Shot Campaign in September
-
Endpoints News
Bluebird’s regulatory chief departed two days after historic gene therapy nod to join Flagship’s Tessera
Aug 23, 2022
-
Reuters
AstraZeneca on hunt for acquisitions - CEO
-
The Wall Street Journal
IPO Market Faces Worst Year in Two Decades. ‘Really Hard Pill to Swallow.’
-
San Francisco Business Times
Behind the scenes of Pfizer’s $5.4 billion buyout of Global Blood Therapeutics
-
STAT
Unlikely protein implicated in mouse study using ALS patients’ spinal fluid
Aug 22, 2022
-
The Wall Street Journal
Biotech Rebounds on Optimism and Deal Making
-
Evaluate Vantage
Esmo 2022 preview: front-line liver cancer showdown
-
The Washington Post
Amid covid surge, Iran cut corners to approve yet-unproven vaccine
-
Reuters
Meagre medicine cabinet leaves Sanofi unloved
Aug 19, 2022
-
Bloomberg
Hundreds of Small Pharmacies Report Trouble Stocking Adderall
-
DCist
How Local Families Cope With Sickle Cell: ‘My Kids Are In Pain Now And Need Relief Now’
-
FierceBiotech
China’s Jemincare nabs $650M biobucks pact with Genentech
-
The New York Times
Forever Chemicals No More? PFAS Are Destroyed With New Technique
Aug 18, 2022
-
The Wall Street Journal
What, Exactly, Is ‘Paxlovid Mouth,’ and How Do You Get Rid of It?
-
Bloomberg
Monkeypox Vaccine Maker Bavarian Nordic No Longer Sure It Can Meet Demand
-
The Financial Times
Covid can cause brain disorders two years after infection, study shows
-
MIT Technology Review
Mini caps can measure activity in lab-grown minibrains
Aug 17, 2022
Aug 16, 2022
-
The Wall Street Journal
Wall Street Deal Making Faces Greater Scrutiny, Delays Under FTC’s Lina Khan
-
Bloomberg
Burst of Broken SPAC Deals Sends Jitters Through Battered Blank-Check Sector
-
Bloomberg
Can Ketamine Help Alcoholics? This Company Plans to Find Out
-
Reuters
Pfizer CEO Bourla shows mild symptoms after testing positive for COVID
Previous
